Keywords

• Bivalirudin
• Bivalirudin Acetate
• 128270-60-0

Quick Details

• ProName: Bivalirudin
• CasNo: 128270-60-0
• Molecular Formula: C98h138n24o33
• Appearance: white powder
• Application: Bivalirudin
• DeliveryTime: 5 days
• PackAge: Vial or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 100 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 10 Milligram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details

Bivalirudin:
CAS No.: 128270-60-0
Sequence: D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH
Bivalirudin is a medication used to manage and treat patients undergoing percutaneous coronary intervention for acute myocardial infarction. It is in the direct thrombin inhibitor class of drugs.  

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.